Year-to-date (YTD) revenue edged down 0.7 per cent at constant currency to £580 million, as the brand continued to prioritise its consumer-first strategy. Dr. Martens said it remains on track to deliver significant year-on-year (YoY) growth in profit before tax (PBT) in FY26.
Dr. Martens has reported resilient Q3 FY26 trading despite a tough retail backdrop, with revenue down 2.7 per cent to £253 million (~$346.6 million) due to tighter promotions.
YTD revenue slipped 0.7 per cent.
Wholesale outperformed, while DTC declined amid a focus on full-price sales.
The Americas led growth.
The company expects flat FY26 revenue and strong YoY PBT growth.
Wholesale continued to outperform, with Q3 revenue rising 9.5 per cent at constant currency and YTD growth of 4.2 per cent. In contrast, direct-to-consumer (DTC) revenue fell 6.5 per cent in the quarter, as the company prioritised full-price sales and curtailed clearance activity. Full-price DTC revenue rose 2 per cent YTD, led by a strong performance in the Americas, Dr. Martens said in a press release.
The Americas remained the standout region, delivering Q3 revenue growth of 2 per cent and YTD growth of 4.5 per cent at constant currency. Retail and wholesale both posted gains, while e-commerce remained flat as promotional intensity was reduced. In Europe, Middle East and Africa (EMEA), revenue declined 6 per cent in Q3 amid a difficult consumer backdrop, with growth shifting towards wholesale partners, particularly in Germany and the UK. Asia Pacific (APAC) revenue fell 3 per cent, though wholesale grew and full-price DTC performance improved, supported by continued strength in South Korea.
“This is a year of pivot, as we make the necessary changes to our business to set us up for future sustainable growth. I remain laser focused on executing our new strategy and we will deliver all four of our strategic objectives for FY26. We have continued to improve the quality of our revenue through a disciplined approach to promotions, and this represents a headwind to overall revenue, particularly in e-commerce,” said Ije Nwokorie, chief executive officer (CEO) at Dr. Martens.
“We remain on track to deliver significant YoY growth in PBT. I am particularly pleased with the performance of our Americas business, with both retail and wholesale showing good growth as a result of the actions taken over the past year. The EMEA market continues to be challenging, with our DTC revenue performance impacted by both the market and our more disciplined promotional stance. We delivered a good Wholesale performance, with growth broad-based across all three regions,” added Nwokorie.
For FY26, Dr. Martens expects revenue to be broadly flat at constant currency, while confirming confidence in market expectations for PBT, implying significant YoY growth. The company now anticipates a foreign exchange headwind of around £15 million to revenue, with a broadly neutral impact on adjusted PBT.
Fibre2Fashion News Desk (SG)
